People: Fresenius Medical Care AG & Co KGaA (FMEG.DE)
53.44EUR
8:30am EDT
€-0.48 (-0.89%)
€51.80
€53.76
€54.50
€53.21
548,790
854,288
€60.27
€47.79
Lipps, Ben
Brief Biography
Dr. Ben J. Lipps has been appointed Honorary Chairman of Fresenius Medical Care AG & Co KGaA effective January 1, 2013. After earning his Master and Doctoral degrees at the Massachusetts Institute of Technology in Chemical Engineering, Dr. Lipps led the research team that developed the first commercial Hollow Fiber Artificial Kidney at the end of the 1960s at DOW Chemical. Dr. Lipps has held the position of Chairman of the Management Board of Fresenius Medical Care Holdings Inc., USA and Member of the Management Board of Fresenius Management SE. He has also acted as Member of the Board of Vifor Fresenius Medical Care Renal Pharma Ltd.
Basic Compensation
| Total Annual Compensation, EUR | Long-Term Incentive Plans, EUR | All Other, EUR | Fiscal Year Total, EUR |
|---|---|---|---|
| 2,077,000 | -- | 2,785,000 | 4,862,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Gerd Krick |
120,000 |
Rice Powell |
3,374,000 |
Ben Lipps |
4,862,000 |
Dieter Schenk |
43,000 |
Michael Brosnan |
2,713,000 |
Oliver Maier |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
